www.clevelanddx.com Open in urlscan Pro
198.185.159.145  Public Scan

Form analysis
0 forms found in the DOM

Text Content

ABOUT US IsoPSA® TESTING OUR SCIENCE NEWS & MEDIA

Back OUR COMPANY LEADERSHIP BOARD OF DIRECTORS INVESTORS CONTACT US CAREERS
Back THE IsoPSA TEST THE IsoPSA EXPERIENCE
Back PLATFORM PUBLICATIONS
Back PRESS RELEASES NEWS


ABOUT US OUR COMPANY LEADERSHIP BOARD OF DIRECTORS INVESTORS CONTACT US CAREERS
IsoPSA® TESTING THE IsoPSA TEST THE IsoPSA EXPERIENCE OUR SCIENCE PLATFORM
PUBLICATIONS NEWS & MEDIA PRESS RELEASES NEWS

Scroll



IMPROVING CANCER DECISIONS


CLEVELAND DIAGNOSTICS OFFERS NOVEL, MORE ACCURATE TESTING FOR EARLY DETECTION OF
CANCER AND RISK OF HIGH-GRADE DISEASE.

LEARN MORE
 
 
 


OUR SOLVENT INTERACTION ANALYSIS PLATFORM


ENABLING THE RAPID DEVELOPMENT OF SIMPLER, CLEARER CANCER DIAGNOSTICS

Our Solvent Interaction Analysis (SIA) based technology measures structural
differences in proteins to determine if biomarkers originated in cancer cells.
This simple yet robust platform enables the efficient development of a portfolio
of affordable blood tests that add clarity to cancer diagnostics.

OUR PLATFORM
 


OUR FIRST TEST: ISOPSA


REDUCES UNNECESSARY PROSTATE BIOPSIES BY UP TO 55%1

With high sensitivity and a specificity two to three times that of traditional
PSA tests, 2-4 IsoPSA clarifies in whom aggressive cancer may reside—and in whom
it may not.

IsoPSA TEST
 

1 Scovell J, et al., Urol. Pract 2022.
2 Klein EA, et al., Eur Urol. 2017.
3 Stovsky M, et al., J Urol. 2019.
4 Podium presentation, AUA-NCS 2021.



Main Message

Science

Insights
 

3615 Superior Ave.
Suite 4407B
Cleveland, OH 44114

ABOUT US
IsoPSA® TESTING
OUR SCIENCE
NEWS & MEDIA


LICENSES
CONTACT US
PRIVACY POLICY



© 2022 Cleveland Diagnostics, Inc.